These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8992575)

  • 1. [Android-type obesity and gynecoid-type obesity].
    Janjic D
    Praxis (Bern 1994); 1996 Dec; 85(49):1578-83. PubMed ID: 8992575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
    Tankó LB; Christiansen C
    Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic difference between visceral fat and subcutaneous abdominal fat].
    Björntorp P
    Diabetes Metab; 2000 Jun; 26 Suppl 3():10-2. PubMed ID: 10945144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
    Qatanani M; Lazar MA
    Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dyslipidemia and abdominal obesity: mechanisms and characteristics (Part I)].
    Farnier M
    Arch Mal Coeur Vaiss; 2007 Dec; 100(12):979-84. PubMed ID: 18223510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone and the metabolic syndrome.
    Johannsson G; Bengtsson BA
    J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obesity epidemic: pathophysiology and consequences of obesity.
    Pi-Sunyer FX
    Obes Res; 2002 Dec; 10 Suppl 2():97S-104S. PubMed ID: 12490658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adipocytokins, obesity and development of type 2 diabetes].
    Lacquemant C; Vasseur F; Leprêtre F; Froguel P
    Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiologic principles of metabolic syndrome. Consequences for early diagnosis and prevention].
    Häring HU
    Fortschr Med; 1992 Dec; 110(34):633-6. PubMed ID: 1483614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue distribution, plasma insulin, and cardiovascular disease.
    Björntorp P
    Diabete Metab; 1987 Jul; 13(3 Pt 2):381-5. PubMed ID: 3308569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism.
    Girard J; Lafontan M
    Diabetes Metab; 2008 Nov; 34(5):439-45. PubMed ID: 18562233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance and adipose tissue gene expression in humans].
    Bastard JP
    Ann Biol Clin (Paris); 2004; 62(1):25-31. PubMed ID: 15047487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.